Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-003180

Chief Business Officer acquired 54,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hull Hans Chief Business Officer 2023-01-25 Grant or award +54,000 192,191 D
Derivatives
Hull Hans Chief Business Officer 2023-01-25 Grant or award · Stock Option (right to buy) +76,200 76,200 D
Loading xslF345X03/form4.xml…